Core Viewpoint - Zhonghong Medical is focusing on innovation and digital technology integration to develop high-performance medical products, aiming to become a leading provider of intelligent medical solutions in the industry [2]. Group 1: Company Overview - Zhonghong Medical is primarily engaged in the research, production, and sales of high-quality disposable protective gloves, with a revenue composition of 89.48% from health protection products, 6.22% from safety infusion products, and 4.30% from innovative incubation products [9]. - The company was established on December 22, 2010, and went public on April 27, 2021, located in Tangshan, Hebei Province [9]. Group 2: Financial Performance - For the period from January to September 2025, Zhonghong Medical achieved a revenue of 1.864 billion yuan, representing a year-on-year growth of 1.38%, while the net profit attributable to shareholders was -7.21 million yuan, a decrease of 114.13% year-on-year [10]. - As of September 30, 2025, the company had a total market capitalization of 5.665 billion yuan [1]. Group 3: Market Position and Strategy - The company exports 81.56% of its revenue, benefiting from the depreciation of the RMB [4]. - Zhonghong Medical employs an ODM direct sales model, producing medical devices and consumables for overseas brand owners, who handle packaging and sales [2]. Group 4: Recent Developments - Zhonghong Medical showcased its products at the 12th Beijing Pet Expo, highlighting its veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture, catering to various clinical scenarios [3].

Group 1 - The core focus of the news is on the recent adjustments made by securities firms to increase their margin financing and securities lending (margin trading) business limits, indicating a strong demand for such services in the A-share market [1][2]. - Caida Securities plans to raise its credit trading business authorization limit from 100% to 140% of its audited net capital for 2024, which will increase its available funds for credit business from 10.842 billion to 15.178 billion yuan, an increase of 4.346 billion yuan [1][2]. - Donghai Securities has also raised its margin financing and securities lending business limit from 10.2 billion to 11 billion yuan, signaling an increase in investment in this area [2]. Group 2 - The overall margin financing balance in the A-share market has seen significant growth, rising from 1.39 trillion yuan at the end of August 2024 to 2.72 trillion yuan by the end of January 2026, an increase of over 1.3 trillion yuan [2]. - Despite a recent slight decline in margin financing data due to policy adjustments and market fluctuations, the demand for margin financing remains strong, with reports of some smaller securities firms exhausting their margin limits [3][4]. - The trading activity in margin financing has decreased, with the proportion of margin trading in A-share transactions dropping to 9.03% as of February 11, down from over 11% prior to a policy change [3][4]. Group 3 - The current decrease in margin trading activity is seen as part of a broader trend of reduced trading volume in the A-share market, which often occurs before long holidays [4][5]. - Market sentiment remains cautiously optimistic for the post-holiday period, with expectations of improved liquidity and a potential recovery in market preferences as funds return [6]. - Regulatory signals indicate a focus on market stability and risk prevention, suggesting a shift towards a more balanced market structure in the medium to long term [6].

Group 1 - The core viewpoint of the news highlights the recent performance of Luoyang Molybdenum Co., Ltd., with a stock price increase of 2.93% and a trading volume of 5.745 billion yuan on February 11 [1] - On February 11, the company had a financing buy-in amount of 513 million yuan and a financing repayment of 401 million yuan, resulting in a net financing buy of 111 million yuan [1] - As of February 11, the total margin balance for Luoyang Molybdenum was 4.837 billion yuan, with the financing balance accounting for 1.19% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - Luoyang Molybdenum Co., Ltd. was established on December 22, 1999, and went public on October 9, 2012, primarily engaged in the mining, processing, and trading of rare metals such as molybdenum, tungsten, and gold [2] - The company's revenue composition includes 48.56% from refined metal product trading, 38.31% from ore product trading, and smaller percentages from copper, cobalt, molybdenum, and other metals [2] - For the period from January to September 2025, Luoyang Molybdenum reported a revenue of 145.485 billion yuan, a year-on-year decrease of 5.99%, while the net profit attributable to shareholders increased by 72.61% to 14.280 billion yuan [2] Group 3 - Since its A-share listing, Luoyang Molybdenum has distributed a total of 21.562 billion yuan in dividends, with 10.576 billion yuan distributed in the last three years [3] - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited, which increased its holdings by 47.472 million shares to 695 million shares [3] - Other notable shareholders include Huaxia SSE 50 ETF and Huatai-PB CSI 300 ETF, with changes in their holdings compared to the previous period [3]

Group 1 - The financing dynamics of Ruiskanda (603803) have attracted market attention, with a financing buy amount of 10.16 million yuan and a financing repayment of 10.90 million yuan, resulting in a net financing sell of 738,300 yuan, while the financing balance remains at 162 million yuan [1] - The short-term market sentiment is reflected in the securities lending activity, with no shares sold short and 1,500 shares repaid [1] Group 2 - Over the past five trading days (February 6 to February 11, 2026), Ruiskanda's stock price fluctuated within a range of 2.78%, with a volatility of 7.15%, and the latest closing price on February 11 was 10.35 yuan [2] - The trading activity was robust, with a single-day trading volume of 189 million yuan on February 10, resulting in a turnover rate of 4.20% [2] - The technical analysis indicates that the stock is in a consolidation phase, with a resistance level at 10.59 yuan and a support level at 9.74 yuan [2]

Core Viewpoint - China International Capital Corporation (CICC) shows strong financial performance with significant revenue and profit growth, alongside high levels of financing and margin trading activity, indicating robust investor interest and market positioning [1][3]. Financing Activity - On February 11, CICC had a financing buy-in amount of 79.38 million yuan, with a net financing outflow of 7.28 million yuan, resulting in a total financing balance of 29.47 billion yuan [1]. - The financing balance of 29.42 billion yuan accounts for 2.86% of the circulating market value, which is above the 80th percentile of the past year, indicating a high level of financing activity [1]. Margin Trading - CICC's margin trading on February 11 included a repayment of 5,400 shares with no shares sold, leading to a margin balance of 4.68 million yuan, which is above the 90th percentile of the past year [1]. Company Overview - CICC, established on July 31, 1995, and listed on November 2, 2020, operates in investment banking, equity sales and trading, fixed income, commodities, wealth management, and investment management [2]. - The revenue composition includes wealth management (32.58%), equity business (25.78%), fixed income (13.38%), investment banking (11.26%), and other segments [2]. Financial Performance - For the period from January to September 2025, CICC reported revenue of 20.76 billion yuan, a year-on-year increase of 54.36%, and a net profit of 6.57 billion yuan, reflecting a 129.75% growth [3]. - CICC has distributed a total of 5.36 billion yuan in dividends since its A-share listing, with 3.04 billion yuan in the last three years [3]. Shareholder Structure - As of September 30, 2025, CICC had 118,900 shareholders, with an average of 24,662 circulating shares per shareholder, showing a decrease in the number of shareholders but an increase in average shares held [3]. - Major shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable increases in holdings for some while others saw reductions [4].

Stock Performance - The stock price of Hangke Technology experienced significant fluctuations, with a cumulative decline of 11.62% from January 26 to January 30, 2026, and a net outflow of 100 million yuan in principal funds [2] - On February 2, 2026, the stock price fell by 3.51%, but rebounded by 5.04% on February 3, indicating notable short-term volatility [2] Capital Movement - As of February 2, 2026, the margin trading balance was 380 million yuan, with the financing balance accounting for 2.16% of the circulating market value, exceeding the 60th percentile level over the past year, indicating active margin trading but with associated risks [3] - The net buying amount on that day was -8.6125 million yuan, reflecting a net outflow [3] Institutional Holdings - Nanhua Fund's Nanhua Ruiying Mixed Fund increased its holdings in Hangke Technology in the fourth quarter of 2025, holding 64,600 shares as of February 3, 2026, which accounted for 7.94% of the fund's net value, making it the second-largest heavy stock [4] - Conversely, HSBC Jintrust series funds reduced their holdings in the third quarter of 2025, indicating divergence among institutions [4] Recent Events of Interest - The actual controller's reduction plan was disclosed between August and September 2025, where Cao Jing and Cao Ji, along with their concerted actions, reduced their holdings by 3%, cashing out approximately 223 million yuan, which may have lingering effects on market sentiment [5] Performance Overview - For the first three quarters of 2025, the company's operating income was 2.721 billion yuan, a year-on-year increase of 1.87%, while the net profit attributable to shareholders was 386 million yuan, up 2.59% year-on-year, although the gross profit margin declined to 28.82% [6] - Future annual performance announcements should be monitored to see if this trend continues [6] Business Development - The company's overseas revenue accounted for 46.01%, and it has deepened cooperation with clients such as Tesla and Toyota, although the long order confirmation cycle may lead to fluctuations in gross profit margin [7]

Content: --------- <doc id='2'>金 融 工 程 研 究 证 券 研 究 报 告 融 资 融 券 周 报</doc> <doc id='9'>1. 市场数据概览 上周（2 月 4 日-2 月 10 日）A 股市场主要指数多数上涨，其中上证 50 涨幅最大， 上涨了 1.74%；创业板指跌幅最大，下跌了 0.13%。此外，上证综指上涨 1.49%， 深证成指上涨 0.59%，科创 50 上涨 0.03%，沪深 300 上涨 1.38%，中证 500 上 涨 0.24%。</doc> <doc id='10'>表 1：A 股市场主要指数上周表现 | 指数名称 | 2 月 3 日收盘价 | 2 月 10 日收盘价 | 周涨跌幅(%) | | --- | --- | --- | --- | | 上证综指 | 4067.74 | 4128.37 | 1.49 | | 深证成指 | 14127.11 | 14210.63 | 0.59 | | 创业板指 | 3324.89 | 3320.54 | -0.13 | | 科创 50 | 1471.07 | 1471.50 | 0.03 | | 沪深 300 | 4660.11 | 4724.30 | 1.38 | | 上证 50 | 3034.58 | 3087.41 | 1.74 | | 中证 500 | 8286.70 | 8306.44 | 0.24 | 资料来源：同花顺，渤海证券研究所 图 1：近一年沪深 300 收盘价与融资买入额占成交额比例</doc> <doc id='12'>资料来源：同花顺，渤海证券研究所 2 月 10 日，沪深两市两融余额为 26,517.83 亿元，较上周减少 459.93 亿元。其 中融资余额为 26,350.49 亿元，较上周减少 460.03 亿元；融券余额为 167.34 亿 元，较上周增加 0.10 亿元。</doc> <doc id='13'>表 2：三市融资融券余额 | 日期 | 沪深京三市余额 | 沪深两市余额 | 沪市余额 | 深市余额 | 京市余额 | 融资余额 | 融券余额 | | --- | --- | --- | --- | --- | --- | --- | --- | | | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | （亿元） | | 2026-02-04 | 26,928.72 | 26,841.25 | 13,598.65 | 13,242.60 | 87.47 | 26,671.51 | 169.74 | | 2026-02-05 | 26,808.60 | 26,721.87 | 13,547.70 | 13,174.17 | 86.73 | 26,553.94 | 167.93 |</doc> <doc id='15'>| 2026-02-06 | 26,636.60 | 26,549.98 | 13,470.36 | 13,079.62 | 86.62 | 26,383.84 | 166.14 | | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-02-09 | 26,644.00 | 26,556.13 | 13,475.12 | 13,081.01 | 87.87 | 26,387.82 | 168.31 | | 2026-02-10 | 26,604.75 | 26,517.83 | 13,459.14 | 13,058.69 | 86.92 | 26,350.49 | 167.34 | 资料来源：同花顺，渤海证券研究所 图 2：近期融资业务情况（亿元） 图 3：近期融券业务情况（亿元）</doc> <doc id='24'>2 月 10 日，融资融券个人投资者数量为 798.23 万名，较上周增长 0.24%；融资 融券机构投资者数量为 51,114 家，较上周增长 0.11%。有融资融券负债的投资者 数量为 1,901,935 名，较上周下降 0.97%。户均融资融券余额为 1,398,825 元， 较上周减少 10,417 元。有融资融券负债的投资者数量占全体融资融券投资者数 量的占比为 23.68%，较上周减少 0.29 个百分点。2 月 4 日-2 月 10 日每日平均 参与融资融券交易的投资者数量为 432,017 名，较前一周下降 17.79%。</doc> <doc id='28'>2. 行业融资融券特征 从申万一级行业来看，煤炭、综合和轻工制造等行业涨幅较大，有色金属、通信 和国防军工等行业跌幅较大。</doc> <doc id='29'>资料来源：同花顺，渤海证券研究所 融资方面，传媒、综合和环保行业融资净买入额较多，有色金属、通信和非银金 融行业融资净买入额较少。</doc> <doc id='32'>资料来源：同花顺，渤海证券研究所 融券方面，上周传媒、煤炭和机械设备行业融券净卖出额较多，有色金属、食品 饮料和国防军工行业融券净卖出额较少。</doc> <doc id='35'>上周融资买入额占成交额比例较高的行业为非银金融、通信和电子，较低的行业 为纺织服饰、轻工制造和建筑材料；融资余额占流通市值比例较高的行业为计算 机、通信和国防军工，较低的行业为石油石化、银行和煤炭。</doc> <doc id='37'>行业名称 融资买入额占成交额(%) 较上周变化(pct.) 融资余额占流通市值(%) 较上周变化(pct.) 非银金融 11.13 0.10 3.04 -0.11 通信 10.57 -0.46 3.42 -0.13 电子 9.17 -0.14 3.13 -0.03 国防军工 8.73 -0.02 3.28 -0.03 计算机 8.63 -0.05 4.09 -0.02 电力设备 8.50 0.06 2.95 -0.07 有色金属 8.40 -1.14 2.76 -0.05 钢铁 8.13 -0.47 1.71 -0.08 银行 7.94 -1.01 0.82 -0.05 传媒 7.89 0.14 3.07 -0.04 煤炭 7.78 -0.79 0.88 -0.10 公用事业 7.74 -0.30 1.73 -0.02 美容护理 7.72 1.11 2.56 -0.12 汽车 7.72 0.01 2.97 -0.08 家用电器 7.67 0.32 2.01 -0.12 医药生物 7.61 -0.37 2.74 -0.11 机械设备 7.38 0.03 2.51 -0.07 建筑装饰 7.35 -0.83 2.37 -0.03 房地产 7.27 -0.45 3.05 -0.17 基础化工 7.25 -0.36 2.31 -0.09 综合 7.17 0.20 2.84 -0.14 农林牧渔 6.84 -0.46 2.73 -0.08 表 3：上周标的券所属行业融资情况</doc> <doc id='39'>| 交通运输 | 6.64 | -1.07 | 1.38 | -0.09 | | --- | --- | --- | --- | --- | | 食品饮料 | 6.62 | -0.13 | 1.16 | -0.05 | | 石油石化 | 6.40 | -0.70 | 0.66 | -0.03 | | 环保 | 6.32 |

Group 1 - The financing dynamics of Senhe Co., Ltd. (301056) have attracted market attention, with a net financing purchase of 583,000 yuan as of February 5, 2026, and a financing balance of 125 million yuan [1] - Over the past three trading days, the cumulative net purchase reached 9.76 million yuan, indicating an increase in short-term capital activity [1] - There has been volatility in fund flows, with a net outflow of 3.37 million yuan on February 9, followed by a net inflow of 1.61 million yuan on February 11, reflecting intensified bullish and bearish competition [1] Group 2 - The stock price of Senhe Co., Ltd. has shown an overall downward trend over the past seven trading days (February 5 to February 11, 2026), with a decline of 5.66% and a fluctuation of 8.12% [2] - On February 10, the stock experienced a significant single-day drop of 3.58%, followed by a slight rebound of 0.55% on February 11, closing at 16.50 yuan [2] - Trading volume and turnover rate peaked on February 6 (turnover rate of 2.96%), subsequently decreasing, with the turnover rate dropping to 1.05% on February 11, indicating cautious market trading [2] - Technically, the stock price is near the lower band of the 20-day Bollinger Bands, with a short-term resistance level to watch at 18.05 yuan [2]

Group 1 - The core business of the company is focused on the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2] - As of September 30, 2025, the company achieved a revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a significant increase of 213.21% [2] - The company has distributed a total of 440 million yuan in dividends since its A-share listing, with 390 million yuan distributed over the past three years [3] Group 2 - As of February 10, 2023, the company's financing balance reached 50 million yuan, accounting for 0.75% of its market capitalization, indicating a high level of financing activity [1] - The company had a net financing purchase of 1.46 million yuan on February 10, 2023, with a total financing buy of 4.19 million yuan and repayment of 2.73 million yuan [1] - The company’s stock has seen an increase in shareholder accounts, with a total of 6,164 shareholders as of September 30, 2025, reflecting a 4.12% increase [2]

Group 1 - The core viewpoint of the news is that Nuwei CNC has shown mixed financial performance, with a slight increase in revenue but a decrease in net profit, indicating potential challenges ahead [2][3]. - As of February 10, Nuwei CNC's stock price remained unchanged, with a trading volume of 36.44 million yuan and a net financing outflow of 2.47 million yuan, suggesting a cautious market sentiment [1]. - The company's financing balance is 139 million yuan, accounting for 1.97% of its market capitalization, which is below the 50th percentile level over the past year, indicating a low level of leverage [1]. Group 2 - For the period from January to September 2025, Nuwei CNC achieved operating revenue of 2.07 billion yuan, representing a year-on-year growth of 12.88%, while the net profit attributable to shareholders decreased by 9.36% to 206 million yuan [2]. - The company has distributed a total of 604 million yuan in dividends since its A-share listing, with 523 million yuan distributed over the past three years, reflecting a commitment to returning value to shareholders [3]. - As of September 30, 2025, the number of shareholders increased by 10.47% to 13,500, while the average circulating shares per person decreased by 9.48% to 33,841 shares, indicating a shift in shareholder dynamics [2].